animenews: U.S. patent office rules against Amgen Humira challenge

Affichage des articles dont le libellé est U.S. patent office rules against Amgen Humira challenge. Afficher tous les articles

jeudi 14 janvier 2016

U.S. patent office rules against Amgen Humira challenge

(Reuters) - U.S. patent officials on Thursday denied petitions by Amgen to review two formulation patents on AbbVie's Humira, a potential setback in Amgen efforts to market a biosimilar version of the world's top-selling prescription medicine.

http://ift.tt/xePdMM

from Reuters: Health News
via animenewspro

animenews

تعديل

jeudi 14 janvier 2016

U.S. patent office rules against Amgen Humira challenge

التسميات

أرشيف المدونة الإلكترونية